nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—Dronabinol—CYP2A6—stomach cancer	0.0174	1	CrCbGaD
Nabilone—CNR2—hematopoietic system—stomach cancer	0.00774	0.505	CbGeAlD
Nabilone—CNR2—lymphoid tissue—stomach cancer	0.00545	0.356	CbGeAlD
Nabilone—CNR1—GPCR ligand binding—HRH4—stomach cancer	0.00225	0.00771	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—KISS1R—stomach cancer	0.00225	0.00768	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00219	0.00749	CbGpPWpGaD
Nabilone—CNR1—N-cadherin signaling events—PIK3CA—stomach cancer	0.00217	0.00741	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00217	0.00741	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—AGTR2—stomach cancer	0.00216	0.0074	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—BDNF—stomach cancer	0.00216	0.00739	CbGpPWpGaD
Nabilone—CNR1—lymph node—stomach cancer	0.00214	0.14	CbGeAlD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00211	0.00721	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—HTR1A—stomach cancer	0.00208	0.00712	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KISS1R—stomach cancer	0.00204	0.00697	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.00204	0.00697	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—FYN—stomach cancer	0.00202	0.0069	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—ANXA1—stomach cancer	0.00201	0.00688	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—KISS1—stomach cancer	0.00201	0.00687	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.00201	0.00686	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00198	0.00679	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.00197	0.00675	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.00193	0.00661	CbGpPWpGaD
Nabilone—CNR2—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00187	0.00638	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.00181	0.00618	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—KISS1R—stomach cancer	0.00176	0.00603	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—IRS2—stomach cancer	0.00173	0.00593	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.00172	0.00588	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.0017	0.00581	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR2—stomach cancer	0.00167	0.00571	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.00166	0.00566	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—F2R—stomach cancer	0.00165	0.00564	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HRH4—stomach cancer	0.00162	0.00555	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—HTR1A—stomach cancer	0.00161	0.00549	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KISS1R—stomach cancer	0.0016	0.00547	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.0016	0.00547	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.0016	0.00547	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ANXA1—stomach cancer	0.00155	0.0053	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.00155	0.00529	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—APC—stomach cancer	0.00153	0.00524	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRB1—stomach cancer	0.0015	0.00514	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRH4—stomach cancer	0.00147	0.00504	CbGpPWpGaD
Nabilone—CNR1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.00146	0.00501	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—KISS1—stomach cancer	0.00145	0.00495	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KISS1—stomach cancer	0.00131	0.00449	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGTR2—stomach cancer	0.00131	0.00448	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—F2R—stomach cancer	0.00129	0.00443	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—HRH4—stomach cancer	0.00127	0.00436	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—HTR1A—stomach cancer	0.00126	0.00431	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.00125	0.00429	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GAST—stomach cancer	0.00124	0.00425	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—RGS2—stomach cancer	0.00124	0.00425	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ANXA1—stomach cancer	0.00122	0.00416	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—ADRB2—stomach cancer	0.00122	0.00416	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KISS1R—stomach cancer	0.0012	0.00412	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GLI3—stomach cancer	0.0012	0.00412	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ADRB1—stomach cancer	0.00118	0.00403	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRH4—stomach cancer	0.00116	0.00396	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RBP1—stomach cancer	0.00115	0.00393	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—KISS1—stomach cancer	0.00114	0.00388	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GAST—stomach cancer	0.00113	0.00386	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—RGS2—stomach cancer	0.00113	0.00386	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—JUN—stomach cancer	0.00105	0.00358	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KISS1—stomach cancer	0.00103	0.00353	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK8—stomach cancer	0.000992	0.00339	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RGS2—stomach cancer	0.000976	0.00334	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GAST—stomach cancer	0.000976	0.00334	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—stomach cancer	0.000971	0.00332	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—ADRB2—stomach cancer	0.000955	0.00327	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLI3—stomach cancer	0.000945	0.00323	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KISS1R—stomach cancer	0.000945	0.00323	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR2—stomach cancer	0.000943	0.00322	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—WWOX—stomach cancer	0.000937	0.0032	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—F2R—stomach cancer	0.000933	0.00319	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—HTR1A—stomach cancer	0.000908	0.0031	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—STAT3—stomach cancer	0.000907	0.0031	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RBP1—stomach cancer	0.000902	0.00308	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GAST—stomach cancer	0.000887	0.00303	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RGS2—stomach cancer	0.000887	0.00303	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ANXA1—stomach cancer	0.000877	0.003	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRH4—stomach cancer	0.000871	0.00298	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—WIF1—stomach cancer	0.000871	0.00298	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK3—stomach cancer	0.000866	0.00296	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AGTR2—stomach cancer	0.000856	0.00293	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—ADRB1—stomach cancer	0.000849	0.0029	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—F2R—stomach cancer	0.000847	0.0029	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HTR1A—stomach cancer	0.000824	0.00282	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—MAPK1—stomach cancer	0.000824	0.00282	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKAB1—stomach cancer	0.000804	0.00275	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ANXA1—stomach cancer	0.000796	0.00272	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RNF43—stomach cancer	0.000776	0.00265	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KISS1—stomach cancer	0.000776	0.00265	CbGpPWpGaD
Nabilone—Pharyngitis—Methotrexate—stomach cancer	0.000773	0.00115	CcSEcCtD
Nabilone—Anxiety—Capecitabine—stomach cancer	0.000773	0.00115	CcSEcCtD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000772	0.00264	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—ADRB1—stomach cancer	0.000771	0.00264	CbGpPWpGaD
Nabilone—Photosensitivity reaction—Doxorubicin—stomach cancer	0.00077	0.00114	CcSEcCtD
Nabilone—Discomfort—Capecitabine—stomach cancer	0.000767	0.00114	CcSEcCtD
Nabilone—Epistaxis—Epirubicin—stomach cancer	0.000766	0.00114	CcSEcCtD
Nabilone—Infection—Docetaxel—stomach cancer	0.000763	0.00113	CcSEcCtD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000762	0.00261	CbGpPWpGaD
Nabilone—Diarrhoea—Irinotecan—stomach cancer	0.00076	0.00113	CcSEcCtD
Nabilone—Dry mouth—Capecitabine—stomach cancer	0.000759	0.00112	CcSEcCtD
Nabilone—Shock—Docetaxel—stomach cancer	0.000756	0.00112	CcSEcCtD
Nabilone—Pruritus—Fluorouracil—stomach cancer	0.000753	0.00112	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—stomach cancer	0.000752	0.00111	CcSEcCtD
Nabilone—Visual impairment—Methotrexate—stomach cancer	0.000751	0.00111	CcSEcCtD
Nabilone—Confusional state—Capecitabine—stomach cancer	0.00075	0.00111	CcSEcCtD
Nabilone—Tachycardia—Docetaxel—stomach cancer	0.00075	0.00111	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AGTR2—stomach cancer	0.00074	0.00253	CbGpPWpGaD
Nabilone—Infection—Capecitabine—stomach cancer	0.000739	0.00109	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—WWOX—stomach cancer	0.000735	0.00251	CbGpPWpGaD
Nabilone—Dizziness—Irinotecan—stomach cancer	0.000735	0.00109	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—stomach cancer	0.000733	0.00109	CcSEcCtD
Nabilone—Anorexia—Docetaxel—stomach cancer	0.000732	0.00109	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—F2R—stomach cancer	0.000732	0.0025	CbGpPWpGaD
Nabilone—Shock—Capecitabine—stomach cancer	0.000732	0.00108	CcSEcCtD
Nabilone—Eye disorder—Methotrexate—stomach cancer	0.000728	0.00108	CcSEcCtD
Nabilone—Diarrhoea—Fluorouracil—stomach cancer	0.000728	0.00108	CcSEcCtD
Nabilone—Tinnitus—Methotrexate—stomach cancer	0.000727	0.00108	CcSEcCtD
Nabilone—Tachycardia—Capecitabine—stomach cancer	0.000726	0.00108	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—stomach cancer	0.000726	0.00108	CcSEcCtD
Nabilone—Pharyngitis—Epirubicin—stomach cancer	0.000724	0.00107	CcSEcCtD
Nabilone—Hyperhidrosis—Capecitabine—stomach cancer	0.000719	0.00107	CcSEcCtD
Nabilone—Hypotension—Docetaxel—stomach cancer	0.000718	0.00106	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—HTR1A—stomach cancer	0.000712	0.00244	CbGpPWpGaD
Nabilone—Epistaxis—Doxorubicin—stomach cancer	0.000709	0.00105	CcSEcCtD
Nabilone—Anorexia—Capecitabine—stomach cancer	0.000709	0.00105	CcSEcCtD
Nabilone—Vomiting—Irinotecan—stomach cancer	0.000707	0.00105	CcSEcCtD
Nabilone—Dizziness—Fluorouracil—stomach cancer	0.000704	0.00104	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—stomach cancer	0.000703	0.00104	CcSEcCtD
Nabilone—Rash—Irinotecan—stomach cancer	0.000701	0.00104	CcSEcCtD
Nabilone—Dermatitis—Irinotecan—stomach cancer	0.0007	0.00104	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.0007	0.00104	CcSEcCtD
Nabilone—Chills—Methotrexate—stomach cancer	0.000699	0.00104	CcSEcCtD
Nabilone—Headache—Irinotecan—stomach cancer	0.000696	0.00103	CcSEcCtD
Nabilone—Hypotension—Capecitabine—stomach cancer	0.000695	0.00103	CcSEcCtD
Nabilone—Insomnia—Docetaxel—stomach cancer	0.000695	0.00103	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FST—stomach cancer	0.000692	0.00237	CbGpPWpGaD
Nabilone—Paraesthesia—Docetaxel—stomach cancer	0.00069	0.00102	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—ADRB2—stomach cancer	0.000688	0.00235	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—ANXA1—stomach cancer	0.000688	0.00235	CbGpPWpGaD
Nabilone—Dyspnoea—Docetaxel—stomach cancer	0.000685	0.00101	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HRH4—stomach cancer	0.000683	0.00234	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—WIF1—stomach cancer	0.000683	0.00234	CbGpPWpGaD
Nabilone—Somnolence—Docetaxel—stomach cancer	0.000683	0.00101	CcSEcCtD
Nabilone—Eye disorder—Epirubicin—stomach cancer	0.000682	0.00101	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—stomach cancer	0.00068	0.00101	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000678	0.001	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—HBEGF—stomach cancer	0.000677	0.00231	CbGpPWpGaD
Nabilone—Flushing—Epirubicin—stomach cancer	0.000677	0.001	CcSEcCtD
Nabilone—Vomiting—Fluorouracil—stomach cancer	0.000677	0.001	CcSEcCtD
Nabilone—Dyspepsia—Docetaxel—stomach cancer	0.000676	0.001	CcSEcCtD
Nabilone—Insomnia—Capecitabine—stomach cancer	0.000673	0.000997	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGTR2—stomach cancer	0.000672	0.0023	CbGpPWpGaD
Nabilone—Hypoaesthesia—Doxorubicin—stomach cancer	0.000671	0.000995	CcSEcCtD
Nabilone—Rash—Fluorouracil—stomach cancer	0.000671	0.000994	CcSEcCtD
Nabilone—Dermatitis—Fluorouracil—stomach cancer	0.00067	0.000994	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—stomach cancer	0.00067	0.000993	CcSEcCtD
Nabilone—Paraesthesia—Capecitabine—stomach cancer	0.000668	0.00099	CcSEcCtD
Nabilone—Decreased appetite—Docetaxel—stomach cancer	0.000668	0.00099	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RGS2—stomach cancer	0.000668	0.00228	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GAST—stomach cancer	0.000668	0.00228	CbGpPWpGaD
Nabilone—Headache—Fluorouracil—stomach cancer	0.000667	0.000988	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—ADRB1—stomach cancer	0.000666	0.00228	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—F2R—stomach cancer	0.000664	0.00227	CbGpPWpGaD
Nabilone—Dyspnoea—Capecitabine—stomach cancer	0.000663	0.000983	CcSEcCtD
Nabilone—Fatigue—Docetaxel—stomach cancer	0.000662	0.000981	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—HRAS—stomach cancer	0.000662	0.00226	CbGpPWpGaD
Nabilone—Nausea—Irinotecan—stomach cancer	0.00066	0.000978	CcSEcCtD
Nabilone—Pain—Docetaxel—stomach cancer	0.000657	0.000973	CcSEcCtD
Nabilone—Constipation—Docetaxel—stomach cancer	0.000657	0.000973	CcSEcCtD
Nabilone—Back pain—Methotrexate—stomach cancer	0.000656	0.000972	CcSEcCtD
Nabilone—Dyspepsia—Capecitabine—stomach cancer	0.000655	0.00097	CcSEcCtD
Nabilone—Chills—Epirubicin—stomach cancer	0.000654	0.00097	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—stomach cancer	0.000652	0.000965	CcSEcCtD
Nabilone—Visual impairment—Doxorubicin—stomach cancer	0.00065	0.000964	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—HTR1A—stomach cancer	0.000647	0.00221	CbGpPWpGaD
Nabilone—Decreased appetite—Capecitabine—stomach cancer	0.000647	0.000958	CcSEcCtD
Nabilone—Fatigue—Capecitabine—stomach cancer	0.000641	0.00095	CcSEcCtD
Nabilone—Vision blurred—Methotrexate—stomach cancer	0.000639	0.000947	CcSEcCtD
Nabilone—Pain—Capecitabine—stomach cancer	0.000636	0.000943	CcSEcCtD
Nabilone—Constipation—Capecitabine—stomach cancer	0.000636	0.000943	CcSEcCtD
Nabilone—Feeling abnormal—Docetaxel—stomach cancer	0.000633	0.000938	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGG—stomach cancer	0.000633	0.00216	CbGpPWpGaD
Nabilone—Nausea—Fluorouracil—stomach cancer	0.000632	0.000937	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PRKAB1—stomach cancer	0.000631	0.00216	CbGpPWpGaD
Nabilone—Eye disorder—Doxorubicin—stomach cancer	0.000631	0.000935	CcSEcCtD
Nabilone—Ill-defined disorder—Methotrexate—stomach cancer	0.000629	0.000933	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—stomach cancer	0.000629	0.000932	CcSEcCtD
Nabilone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000628	0.000931	CcSEcCtD
Nabilone—Anaemia—Methotrexate—stomach cancer	0.000627	0.000929	CcSEcCtD
Nabilone—Flushing—Doxorubicin—stomach cancer	0.000626	0.000928	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—ADRB2—stomach cancer	0.000625	0.00214	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—ANXA1—stomach cancer	0.000625	0.00214	CbGpPWpGaD
Nabilone—Tension—Epirubicin—stomach cancer	0.000623	0.000923	CcSEcCtD
Nabilone—Nervousness—Epirubicin—stomach cancer	0.000617	0.000914	CcSEcCtD
Nabilone—Back pain—Epirubicin—stomach cancer	0.000614	0.00091	CcSEcCtD
Nabilone—Feeling abnormal—Capecitabine—stomach cancer	0.000613	0.000908	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000612	0.00209	CbGpPWpGaD
Nabilone—Malaise—Methotrexate—stomach cancer	0.000612	0.000907	CcSEcCtD
Nabilone—Vertigo—Methotrexate—stomach cancer	0.00061	0.000903	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—RNF43—stomach cancer	0.000609	0.00208	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKAA1—stomach cancer	0.000609	0.00208	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KISS1—stomach cancer	0.000609	0.00208	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000608	0.000901	CcSEcCtD
Nabilone—Body temperature increased—Docetaxel—stomach cancer	0.000607	0.0009	CcSEcCtD
Nabilone—Abdominal pain—Docetaxel—stomach cancer	0.000607	0.0009	CcSEcCtD
Nabilone—Leukopenia—Methotrexate—stomach cancer	0.000607	0.0009	CcSEcCtD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000606	0.00207	CbGpPWpGaD
Nabilone—Chills—Doxorubicin—stomach cancer	0.000605	0.000897	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ADRB1—stomach cancer	0.000605	0.00207	CbGpPWpGaD
Nabilone—Arrhythmia—Doxorubicin—stomach cancer	0.000603	0.000893	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—stomach cancer	0.000598	0.000887	CcSEcCtD
Nabilone—Cough—Methotrexate—stomach cancer	0.000592	0.000877	CcSEcCtD
Nabilone—Ill-defined disorder—Epirubicin—stomach cancer	0.000589	0.000873	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RBP4—stomach cancer	0.000588	0.00201	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—stomach cancer	0.000588	0.00201	CbGpPWpGaD
Nabilone—Body temperature increased—Capecitabine—stomach cancer	0.000588	0.000871	CcSEcCtD
Nabilone—Abdominal pain—Capecitabine—stomach cancer	0.000588	0.000871	CcSEcCtD
Nabilone—Convulsion—Methotrexate—stomach cancer	0.000588	0.000871	CcSEcCtD
Nabilone—Anaemia—Epirubicin—stomach cancer	0.000587	0.00087	CcSEcCtD
Nabilone—Agitation—Epirubicin—stomach cancer	0.000583	0.000865	CcSEcCtD
Nabilone—Myalgia—Methotrexate—stomach cancer	0.000578	0.000856	CcSEcCtD
Nabilone—Arthralgia—Methotrexate—stomach cancer	0.000578	0.000856	CcSEcCtD
Nabilone—Chest pain—Methotrexate—stomach cancer	0.000578	0.000856	CcSEcCtD
Nabilone—Tension—Doxorubicin—stomach cancer	0.000576	0.000854	CcSEcCtD
Nabilone—Malaise—Epirubicin—stomach cancer	0.000573	0.000848	CcSEcCtD
Nabilone—Discomfort—Methotrexate—stomach cancer	0.000571	0.000846	CcSEcCtD
Nabilone—Nervousness—Doxorubicin—stomach cancer	0.000571	0.000845	CcSEcCtD
Nabilone—Vertigo—Epirubicin—stomach cancer	0.00057	0.000845	CcSEcCtD
Nabilone—Syncope—Epirubicin—stomach cancer	0.000569	0.000844	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—stomach cancer	0.000568	0.000842	CcSEcCtD
Nabilone—Back pain—Doxorubicin—stomach cancer	0.000568	0.000842	CcSEcCtD
Nabilone—Hypersensitivity—Docetaxel—stomach cancer	0.000566	0.000839	CcSEcCtD
Nabilone—Palpitations—Epirubicin—stomach cancer	0.000561	0.000831	CcSEcCtD
Nabilone—Confusional state—Methotrexate—stomach cancer	0.000558	0.000827	CcSEcCtD
Nabilone—Loss of consciousness—Epirubicin—stomach cancer	0.000558	0.000827	CcSEcCtD
Nabilone—Cough—Epirubicin—stomach cancer	0.000554	0.000821	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—stomach cancer	0.000554	0.00082	CcSEcCtD
Nabilone—Asthenia—Docetaxel—stomach cancer	0.000551	0.000817	CcSEcCtD
Nabilone—Convulsion—Epirubicin—stomach cancer	0.00055	0.000815	CcSEcCtD
Nabilone—Infection—Methotrexate—stomach cancer	0.00055	0.000815	CcSEcCtD
Nabilone—Hypertension—Epirubicin—stomach cancer	0.000548	0.000812	CcSEcCtD
Nabilone—Hypersensitivity—Capecitabine—stomach cancer	0.000548	0.000812	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000545	0.000808	CcSEcCtD
Nabilone—Pruritus—Docetaxel—stomach cancer	0.000543	0.000805	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FST—stomach cancer	0.000543	0.00186	CbGpPWpGaD
Nabilone—Anaemia—Doxorubicin—stomach cancer	0.000543	0.000805	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—stomach cancer	0.00054	0.000801	CcSEcCtD
Nabilone—Myalgia—Epirubicin—stomach cancer	0.00054	0.000801	CcSEcCtD
Nabilone—Chest pain—Epirubicin—stomach cancer	0.00054	0.000801	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—ADRB2—stomach cancer	0.00054	0.00185	CbGpPWpGaD
Nabilone—Agitation—Doxorubicin—stomach cancer	0.00054	0.0008	CcSEcCtD
Nabilone—Anxiety—Epirubicin—stomach cancer	0.000539	0.000798	CcSEcCtD
Nabilone—Hyperhidrosis—Methotrexate—stomach cancer	0.000535	0.000793	CcSEcCtD
Nabilone—Discomfort—Epirubicin—stomach cancer	0.000534	0.000791	CcSEcCtD
Nabilone—Asthenia—Capecitabine—stomach cancer	0.000534	0.000791	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—HBEGF—stomach cancer	0.000531	0.00182	CbGpPWpGaD
Nabilone—Malaise—Doxorubicin—stomach cancer	0.00053	0.000785	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—stomach cancer	0.000529	0.000783	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—stomach cancer	0.000528	0.000782	CcSEcCtD
Nabilone—Anorexia—Methotrexate—stomach cancer	0.000528	0.000782	CcSEcCtD
Nabilone—Syncope—Doxorubicin—stomach cancer	0.000527	0.000781	CcSEcCtD
Nabilone—Pruritus—Capecitabine—stomach cancer	0.000526	0.00078	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—stomach cancer	0.000526	0.000779	CcSEcCtD
Nabilone—Diarrhoea—Docetaxel—stomach cancer	0.000526	0.000779	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GAST—stomach cancer	0.000524	0.00179	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RGS2—stomach cancer	0.000524	0.00179	CbGpPWpGaD
Nabilone—Confusional state—Epirubicin—stomach cancer	0.000522	0.000774	CcSEcCtD
Nabilone—Palpitations—Doxorubicin—stomach cancer	0.000519	0.000769	CcSEcCtD
Nabilone—Hypotension—Methotrexate—stomach cancer	0.000517	0.000767	CcSEcCtD
Nabilone—Loss of consciousness—Doxorubicin—stomach cancer	0.000516	0.000765	CcSEcCtD
Nabilone—Infection—Epirubicin—stomach cancer	0.000515	0.000763	CcSEcCtD
Nabilone—Cough—Doxorubicin—stomach cancer	0.000513	0.00076	CcSEcCtD
Nabilone—Shock—Epirubicin—stomach cancer	0.00051	0.000755	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—stomach cancer	0.000509	0.000754	CcSEcCtD
Nabilone—Diarrhoea—Capecitabine—stomach cancer	0.000509	0.000754	CcSEcCtD
Nabilone—Dizziness—Docetaxel—stomach cancer	0.000508	0.000753	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—stomach cancer	0.000507	0.000752	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HSPB1—stomach cancer	0.000506	0.00173	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AGTR2—stomach cancer	0.000506	0.00173	CbGpPWpGaD
Nabilone—Tachycardia—Epirubicin—stomach cancer	0.000506	0.000749	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000504	0.000748	CcSEcCtD
Nabilone—Hyperhidrosis—Epirubicin—stomach cancer	0.000501	0.000742	CcSEcCtD
Nabilone—Insomnia—Methotrexate—stomach cancer	0.000501	0.000742	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—BMP2—stomach cancer	0.0005	0.00171	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—F2R—stomach cancer	0.0005	0.00171	CbGpPWpGaD
Nabilone—Chest pain—Doxorubicin—stomach cancer	0.0005	0.000741	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—stomach cancer	0.0005	0.000741	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—stomach cancer	0.0005	0.000741	CcSEcCtD
Nabilone—Anxiety—Doxorubicin—stomach cancer	0.000498	0.000739	CcSEcCtD
Nabilone—Paraesthesia—Methotrexate—stomach cancer	0.000497	0.000737	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—FGG—stomach cancer	0.000497	0.0017	CbGpPWpGaD
Nabilone—Discomfort—Doxorubicin—stomach cancer	0.000494	0.000732	CcSEcCtD
Nabilone—Anorexia—Epirubicin—stomach cancer	0.000494	0.000732	CcSEcCtD
Nabilone—Dyspnoea—Methotrexate—stomach cancer	0.000494	0.000732	CcSEcCtD
Nabilone—Somnolence—Methotrexate—stomach cancer	0.000492	0.000729	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—AKR1C3—stomach cancer	0.000492	0.00168	CbGpPWpGaD
Nabilone—Dizziness—Capecitabine—stomach cancer	0.000492	0.000729	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—ADRB2—stomach cancer	0.00049	0.00168	CbGpPWpGaD
Nabilone—Dry mouth—Doxorubicin—stomach cancer	0.000489	0.000725	CcSEcCtD
Nabilone—Vomiting—Docetaxel—stomach cancer	0.000488	0.000724	CcSEcCtD
Nabilone—Dyspepsia—Methotrexate—stomach cancer	0.000487	0.000722	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HTR1A—stomach cancer	0.000487	0.00167	CbGpPWpGaD
Nabilone—Rash—Docetaxel—stomach cancer	0.000484	0.000718	CcSEcCtD
Nabilone—Hypotension—Epirubicin—stomach cancer	0.000484	0.000717	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—stomach cancer	0.000484	0.000717	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—stomach cancer	0.000483	0.000716	CcSEcCtD
Nabilone—Decreased appetite—Methotrexate—stomach cancer	0.000481	0.000713	CcSEcCtD
Nabilone—Headache—Docetaxel—stomach cancer	0.000481	0.000713	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PPP2R1A—stomach cancer	0.00048	0.00164	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKAA1—stomach cancer	0.000478	0.00163	CbGpPWpGaD
Nabilone—Fatigue—Methotrexate—stomach cancer	0.000477	0.000707	CcSEcCtD
Nabilone—Infection—Doxorubicin—stomach cancer	0.000476	0.000706	CcSEcCtD
Nabilone—Pain—Methotrexate—stomach cancer	0.000473	0.000702	CcSEcCtD
Nabilone—Vomiting—Capecitabine—stomach cancer	0.000473	0.000701	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000472	0.0007	CcSEcCtD
Nabilone—Shock—Doxorubicin—stomach cancer	0.000472	0.000699	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PRKCB—stomach cancer	0.000472	0.00161	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ANXA1—stomach cancer	0.00047	0.00161	CbGpPWpGaD
Nabilone—Rash—Capecitabine—stomach cancer	0.000469	0.000695	CcSEcCtD
Nabilone—Insomnia—Epirubicin—stomach cancer	0.000469	0.000694	CcSEcCtD
Nabilone—Dermatitis—Capecitabine—stomach cancer	0.000469	0.000694	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—stomach cancer	0.000468	0.000693	CcSEcCtD
Nabilone—Headache—Capecitabine—stomach cancer	0.000466	0.00069	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—stomach cancer	0.000465	0.000689	CcSEcCtD
Nabilone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000463	0.000687	CcSEcCtD
Nabilone—Dyspnoea—Epirubicin—stomach cancer	0.000462	0.000685	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—RBP4—stomach cancer	0.000462	0.00158	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—stomach cancer	0.000461	0.00158	CbGpPWpGaD
Nabilone—Somnolence—Epirubicin—stomach cancer	0.000461	0.000683	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—stomach cancer	0.000457	0.000677	CcSEcCtD
Nabilone—Nausea—Docetaxel—stomach cancer	0.000456	0.000676	CcSEcCtD
Nabilone—Feeling abnormal—Methotrexate—stomach cancer	0.000456	0.000676	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—stomach cancer	0.000456	0.000676	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—ADRB1—stomach cancer	0.000456	0.00156	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000453	0.000671	CcSEcCtD
Nabilone—Decreased appetite—Epirubicin—stomach cancer	0.00045	0.000667	CcSEcCtD
Nabilone—Hypotension—Doxorubicin—stomach cancer	0.000448	0.000664	CcSEcCtD
Nabilone—Fatigue—Epirubicin—stomach cancer	0.000447	0.000662	CcSEcCtD
Nabilone—Pain—Epirubicin—stomach cancer	0.000443	0.000657	CcSEcCtD
Nabilone—Constipation—Epirubicin—stomach cancer	0.000443	0.000657	CcSEcCtD
Nabilone—Nausea—Capecitabine—stomach cancer	0.000442	0.000655	CcSEcCtD
Nabilone—Abdominal pain—Methotrexate—stomach cancer	0.000438	0.000649	CcSEcCtD
Nabilone—Body temperature increased—Methotrexate—stomach cancer	0.000438	0.000649	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000437	0.000647	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—RPS6—stomach cancer	0.000435	0.00149	CbGpPWpGaD
Nabilone—Insomnia—Doxorubicin—stomach cancer	0.000434	0.000643	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—stomach cancer	0.00043	0.000638	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PRKCB—stomach cancer	0.000428	0.00146	CbGpPWpGaD
Nabilone—Dyspnoea—Doxorubicin—stomach cancer	0.000427	0.000633	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—stomach cancer	0.000427	0.000633	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL6ST—stomach cancer	0.000426	0.00146	CbGpPWpGaD
Nabilone—Somnolence—Doxorubicin—stomach cancer	0.000426	0.000632	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000424	0.000628	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—stomach cancer	0.000422	0.000625	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—stomach cancer	0.000417	0.000618	CcSEcCtD
Nabilone—Fatigue—Doxorubicin—stomach cancer	0.000413	0.000613	CcSEcCtD
Nabilone—Pain—Doxorubicin—stomach cancer	0.00041	0.000608	CcSEcCtD
Nabilone—Constipation—Doxorubicin—stomach cancer	0.00041	0.000608	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—stomach cancer	0.00041	0.000607	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—stomach cancer	0.00041	0.000607	CcSEcCtD
Nabilone—Hypersensitivity—Methotrexate—stomach cancer	0.000408	0.000605	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HBEGF—stomach cancer	0.0004	0.00137	CbGpPWpGaD
Nabilone—Asthenia—Methotrexate—stomach cancer	0.000397	0.000589	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AGTR2—stomach cancer	0.000397	0.00136	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HSPB1—stomach cancer	0.000397	0.00136	CbGpPWpGaD
Nabilone—Feeling abnormal—Doxorubicin—stomach cancer	0.000395	0.000585	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—BMP2—stomach cancer	0.000393	0.00134	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—F2R—stomach cancer	0.000393	0.00134	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000392	0.000581	CcSEcCtD
Nabilone—Pruritus—Methotrexate—stomach cancer	0.000392	0.00058	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AKR1C3—stomach cancer	0.000386	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HTR1A—stomach cancer	0.000382	0.00131	CbGpPWpGaD
Nabilone—Hypersensitivity—Epirubicin—stomach cancer	0.000382	0.000566	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—IL6R—stomach cancer	0.00038	0.0013	CbGpPWpGaD
Nabilone—Abdominal pain—Doxorubicin—stomach cancer	0.000379	0.000562	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—stomach cancer	0.000379	0.000562	CcSEcCtD
Nabilone—Diarrhoea—Methotrexate—stomach cancer	0.000379	0.000561	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—RHOA—stomach cancer	0.000378	0.00129	CbGpPWpGaD
Nabilone—Asthenia—Epirubicin—stomach cancer	0.000372	0.000551	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PRKCB—stomach cancer	0.00037	0.00127	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ANXA1—stomach cancer	0.000369	0.00126	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ADRB2—stomach cancer	0.000369	0.00126	CbGpPWpGaD
Nabilone—Pruritus—Epirubicin—stomach cancer	0.000367	0.000543	CcSEcCtD
Nabilone—Dizziness—Methotrexate—stomach cancer	0.000366	0.000543	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PPP2R1A—stomach cancer	0.000362	0.00124	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB1—stomach cancer	0.000357	0.00122	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—stomach cancer	0.000355	0.000525	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—stomach cancer	0.000353	0.000523	CcSEcCtD
Nabilone—Vomiting—Methotrexate—stomach cancer	0.000352	0.000522	CcSEcCtD
Nabilone—Rash—Methotrexate—stomach cancer	0.000349	0.000517	CcSEcCtD
Nabilone—Dermatitis—Methotrexate—stomach cancer	0.000349	0.000517	CcSEcCtD
Nabilone—Headache—Methotrexate—stomach cancer	0.000347	0.000514	CcSEcCtD
Nabilone—Asthenia—Doxorubicin—stomach cancer	0.000344	0.00051	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—RHOA—stomach cancer	0.000344	0.00118	CbGpPWpGaD
Nabilone—Dizziness—Epirubicin—stomach cancer	0.000343	0.000508	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—RPS6—stomach cancer	0.000341	0.00117	CbGpPWpGaD
Nabilone—Pruritus—Doxorubicin—stomach cancer	0.000339	0.000503	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PRKCB—stomach cancer	0.000336	0.00115	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SMAD4—stomach cancer	0.000336	0.00115	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6ST—stomach cancer	0.000335	0.00114	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—stomach cancer	0.000332	0.00114	CbGpPWpGaD
Nabilone—Vomiting—Epirubicin—stomach cancer	0.000329	0.000488	CcSEcCtD
Nabilone—Nausea—Methotrexate—stomach cancer	0.000329	0.000487	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—stomach cancer	0.000328	0.000486	CcSEcCtD
Nabilone—Rash—Epirubicin—stomach cancer	0.000327	0.000484	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—stomach cancer	0.000326	0.000484	CcSEcCtD
Nabilone—Headache—Epirubicin—stomach cancer	0.000325	0.000481	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FYN—stomach cancer	0.000319	0.00109	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—stomach cancer	0.000317	0.00047	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HBEGF—stomach cancer	0.000314	0.00107	CbGpPWpGaD
Nabilone—Nausea—Epirubicin—stomach cancer	0.000308	0.000456	CcSEcCtD
Nabilone—Vomiting—Doxorubicin—stomach cancer	0.000305	0.000452	CcSEcCtD
Nabilone—Rash—Doxorubicin—stomach cancer	0.000302	0.000448	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—stomach cancer	0.000302	0.000448	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCL8—stomach cancer	0.000302	0.00103	CbGpPWpGaD
Nabilone—Headache—Doxorubicin—stomach cancer	0.0003	0.000445	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—FGFR2—stomach cancer	0.000299	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6R—stomach cancer	0.000299	0.00102	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—RHOA—stomach cancer	0.000297	0.00102	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ADRB2—stomach cancer	0.00029	0.00099	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—stomach cancer	0.000285	0.000422	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PPP2R1A—stomach cancer	0.000284	0.00097	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IRS2—stomach cancer	0.000274	0.000937	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—RHOA—stomach cancer	0.00027	0.000922	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CAV1—stomach cancer	0.000266	0.000909	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOA1—stomach cancer	0.000265	0.000907	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SMAD4—stomach cancer	0.000264	0.000901	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—stomach cancer	0.000261	0.000892	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRKCB—stomach cancer	0.000253	0.000865	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6ST—stomach cancer	0.000252	0.000861	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FYN—stomach cancer	0.00025	0.000855	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APC—stomach cancer	0.000242	0.000828	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CXCL8—stomach cancer	0.000237	0.00081	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—FGFR2—stomach cancer	0.000235	0.000803	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK3—stomach cancer	0.000232	0.000793	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6R—stomach cancer	0.000225	0.000769	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—MAPK1—stomach cancer	0.000221	0.000754	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—EGFR—stomach cancer	0.000221	0.000754	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IRS2—stomach cancer	0.000215	0.000735	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—stomach cancer	0.000211	0.000721	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SERPINE1—stomach cancer	0.00021	0.00072	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CAV1—stomach cancer	0.000209	0.000713	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—KRAS—stomach cancer	0.000208	0.000712	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOA1—stomach cancer	0.000208	0.000711	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—RHOA—stomach cancer	0.000203	0.000694	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOS3—stomach cancer	0.000201	0.000687	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRKCB—stomach cancer	0.000198	0.000679	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6ST—stomach cancer	0.000198	0.000676	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—stomach cancer	0.000191	0.000654	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APC—stomach cancer	0.00019	0.000649	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ERBB2—stomach cancer	0.000188	0.000643	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK3—stomach cancer	0.000182	0.000622	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—stomach cancer	0.000178	0.000609	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—stomach cancer	0.000177	0.000606	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6R—stomach cancer	0.000176	0.000603	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1B—stomach cancer	0.000174	0.000595	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—MAPK1—stomach cancer	0.000173	0.000592	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—stomach cancer	0.000173	0.000592	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IL6—stomach cancer	0.000169	0.00058	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—stomach cancer	0.000166	0.000568	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—JUN—stomach cancer	0.000166	0.000567	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—stomach cancer	0.000165	0.000566	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SERPINE1—stomach cancer	0.000165	0.000565	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—stomach cancer	0.000163	0.000559	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—stomach cancer	0.000161	0.000551	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CDKN1A—stomach cancer	0.000161	0.000549	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—RHOA—stomach cancer	0.000159	0.000545	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOS3—stomach cancer	0.000158	0.000539	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK8—stomach cancer	0.000157	0.000536	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—stomach cancer	0.00015	0.000514	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ERBB2—stomach cancer	0.000147	0.000504	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—stomach cancer	0.000145	0.000495	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—stomach cancer	0.000143	0.00049	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—stomach cancer	0.00014	0.000478	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—stomach cancer	0.000139	0.000475	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK3—stomach cancer	0.000137	0.000468	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1B—stomach cancer	0.000137	0.000467	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—stomach cancer	0.000133	0.000455	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IL6—stomach cancer	0.000133	0.000455	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MAPK1—stomach cancer	0.00013	0.000446	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—stomach cancer	0.00013	0.000446	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—stomach cancer	0.00013	0.000445	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JUN—stomach cancer	0.00013	0.000445	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—stomach cancer	0.000127	0.000433	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CDKN1A—stomach cancer	0.000126	0.000431	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—stomach cancer	0.000123	0.000421	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK8—stomach cancer	0.000123	0.000421	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—stomach cancer	0.000114	0.000388	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—stomach cancer	0.000113	0.000387	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—stomach cancer	0.000112	0.000385	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—stomach cancer	0.000109	0.000374	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK3—stomach cancer	0.000107	0.000367	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—stomach cancer	0.000105	0.000358	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—stomach cancer	0.000105	0.000357	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MAPK1—stomach cancer	0.000102	0.00035	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—stomach cancer	0.000102	0.00035	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—IL6—stomach cancer	0.0001	0.000342	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—stomach cancer	9.66e-05	0.00033	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—stomach cancer	8.87e-05	0.000303	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—stomach cancer	8.58e-05	0.000293	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—stomach cancer	8.21e-05	0.000281	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IL6—stomach cancer	7.86e-05	0.000269	CbGpPWpGaD
